CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Molecular Therapy2016Vol. 24(9), pp. 1561–1569
Citations Over TimeTop 1% of 2016 papers
Megan D. Hoban, Dianne Lumaquin, Caroline Y. Kuo, Zulema Romero, Joseph Long, Michelle Ho, Courtney S. Young, Michelle Mojadidi, Sorel Fitz‐Gibbon, Aaron Cooper, Georgia R. Lill, Fabrizia Urbinati, Beatriz Campo-Fernández, Carmen Flores, Matteo Pellegrini, Roger P. Hollis, Donald B. Kohn
Related Papers
- → Genome editing and the next generation of antiviral therapy(2016)45 cited
- → Advances in genetic modification of farm animals using zinc-finger nucleases (ZFN)(2015)23 cited
- → Gene editing in small and large animals for translational medicine: a review(2024)8 cited
- Targeted genome editing using site-specific nucleases : ZFNs, TALENs, and the CRISPR/Cas9 system(2015)
- → Gene editing technologies used to reduce infectious plant diseases(2023)1 cited